Skip to main content

Advertisement

SpringerLink
Log in

Treatment of radiation-induced myelopathy with bevacizumab

  • Correspondence
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Abbreviations

MRI:

Magnetic resonance imaging

Gy:

Gray

PET:

Positron emission tomography

SPECT:

Single photon emission computed tomography

CNS:

Central nervous system

IMRT:

Intensity-modulated radiotherapy

VEGF:

Vascular endothelial growth factor

PTV:

Planning target volume

GTV:

Gross tumor volume

References

  1. Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, Bentzen SM, Nam J, Deasy JO. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol. 2010;76:S10–S1919. https://doi.org/10.1016/j.ijrobp.2009.07.1754.

    Article  Google Scholar 

  2. Fowler JF, Bentzen SM, Bond SJ, Ang KK, van der Kogel AJ, van den Bogaert W, van der Schueren E. Clinical radiation doses for spinal cord: the 1998 international questionnaire. Radiother Oncol. 2000;55:295–300.

    Article  CAS  Google Scholar 

  3. Tye K, Engelhard HH, Slavin KV, Nicholas MK, Chmura SJ, Kwok Y, Ho DS, Weichselbaum RR, Koshy M. An analysis of radiation necrosis of the central nervous system treated with bevacizumab. J Neurooncol. 2014;117:321–7. https://doi.org/10.1007/s11060-014-1391-8.

    Article  CAS  PubMed  Google Scholar 

  4. Psimaras D, Tafani C, Ducray F, Leclercq D, Feuvret L, Delattre JY, Ricard D. Bevacizumab in late-onset radiation-induced myelopathy. Neurology. 2016;86:454–7. https://doi.org/10.1212/WNL.0000000000002345.

    Article  CAS  PubMed  Google Scholar 

  5. Liu AK, Macy ME, Foreman NK. Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas. Int J Radiat Oncol Biol Phys. 2009;75:1148–54. https://doi.org/10.1016/j.ijrobp.2008.12.032.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Barisano G, Bergamaschi S, Acharya J, Rajamohan A, Gibbs W, Kim P, Zada G, Chang E, Law M. Complications of radiotherapy and radiosurgery in the brain and spine. Neurographics. 2018;8:167–87. https://doi.org/10.3174/ng.1700066.

    Article  Google Scholar 

  7. Wong CS, Fehlings MG, Sahgal A. Pathobiology of radiation myelopathy and strategies to mitigate injury. Spinal Cord. 2015;53:574–80. https://doi.org/10.1038/sc.2015.43.

    Article  CAS  PubMed  Google Scholar 

  8. Ruben JD, Dally M, Bailey M, Smith R, McLean CA, Fedele P. Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy. Int J Radiat Oncol Biol Phys. 2006;65:499–508. https://doi.org/10.1016/j.ijrobp.2005.12.002.

    Article  PubMed  Google Scholar 

  9. Drezner N, Hardy KK, Wells E, Vezina G, Ho CY, Packer RJ, Hwang EI. Treatment of pediatric cerebral radiation necrosis: a systematic review. J Neurooncol. 2016;130:141–8. https://doi.org/10.1007/s11060-016-2219-5.

    Article  CAS  PubMed  Google Scholar 

  10. Soussain C, Ricard D, Fike JR, Mazeron J-J, Psimaras D, Delattre J-Y. CNS complications of radiotherapy and chemotherapy. Lancet (London, England). 2009;374:1639–51. https://doi.org/10.1016/S0140-6736(09)61299-X.

    Article  CAS  Google Scholar 

  11. de Pasquale MD, de Ville de Goyet J, Monti L, Grimaldi C, Crocoli A, Castellano A. Bevacizumab combined with chemotherapy in children affected by hepatocellular carcinoma: a single-center experience. Anticancer Res. 2017;37:1489–93. https://doi.org/10.21873/anticanres.11475.

    Article  CAS  Google Scholar 

  12. Parekh C, Jubran R, Erdreich-Epstein A, Panigrahy A, Bluml S, Finlay J, Dhall G. Treatment of children with recurrent high grade gliomas with a bevacizumab containing regimen. J Neurooncol. 2011;103:673–80. https://doi.org/10.1007/s11060-010-0444-x.

    Article  CAS  PubMed  Google Scholar 

  13. Zaky W, Wellner M, Brown RJ, Bluml S, Finlay JL, Dhall G. Treatment of children with diffuse intrinsic pontine gliomas with chemoradiotherapy followed by a combination of temozolomide, irinotecan, and bevacizumab. Pediatr Hematol Oncol. 2013;30:623–32. https://doi.org/10.3109/08880018.2013.829895.

    Article  CAS  PubMed  Google Scholar 

  14. Aguilera DG, Goldman S, Fangusaro J. Bevacizumab and irinotecan in the treatment of children with recurrent/refractory medulloblastoma. Pediatr Blood Cancer. 2011;56:491–4. https://doi.org/10.1002/pbc.22868.

    Article  PubMed  Google Scholar 

  15. Couec M-L, Andre N, Thebaud E, Minckes O, Rialland X, Corradini N, Aerts I, Marec Berard P, Bourdeaut F, Leblond P. Bevacizumab and irinotecan in children with recurrent or refractory brain tumors: toxicity and efficacy trends. Pediatr Blood Cancer. 2012;59:34–8. https://doi.org/10.1002/pbc.24066.

    Article  PubMed  Google Scholar 

  16. Hochart A, Gaillard V, Baroncini M, Andre N, Vannier J-P, Vinchon M, Dubrulle F, Lejeune J-P, Vincent C, Neve V, Sudour Bonnange H, Bonne NX, Leblond P. Bevacizumab decreases vestibular schwannomas growth rate in children and teenagers with neurofibromatosis type 2. J Neurooncol. 2015;124:229–36. https://doi.org/10.1007/s11060-015-1828-8.

    Article  CAS  PubMed  Google Scholar 

  17. Friedman GK, Spiller SE, Harrison DK, Fiveash JB, Reddy AT. Treatment of children with glioblastoma with conformal radiation, temozolomide, and bevacizumab as adjuncts to surgical resection. J Pediatr Hematol Oncol. 2013;35:e123–e126126. https://doi.org/10.1097/MPH.0b013e318282cd7f.

    Article  CAS  PubMed  Google Scholar 

  18. Aguilera D, Mazewski C, Fangusaro J, MacDonald TJ, McNall-Knapp RY, Hayes LL, Kim S, Castellino RC. Response to bevacizumab, irinotecan, and temozolomide in children with relapsed medulloblastoma: a multi-institutional experience. Childs Nerv Syst. 2013;29:589–96. https://doi.org/10.1007/s00381-012-2013-4.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Pansy J, Fritsch P, Sovinz P, Lackner H, Schwinger W, Urban C, Benesch M. Add-on-therapy with bevacizumab in children and adolescents with poor prognosis non-CNS solid tumors. Anticancer Drugs. 2013;24:198–203. https://doi.org/10.1097/CAD.0b013e32835b9589.

    Article  CAS  PubMed  Google Scholar 

  20. Saab R, Furman WL. Epidemiology and management options for colorectal cancer in children. Paediatr Drugs. 2008;10:177–92.

    Article  Google Scholar 

  21. Levin VA, Bidaut L, Hou P, Kumar AJ, Wefel JS, Bekele BN, Grewal J, Prabhu S, Loghin M, Gilbert MR, Jackson EF. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys. 2011;79:1487–95. https://doi.org/10.1016/j.ijrobp.2009.12.061.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Gonzalez J, Kumar AJ, Conrad CA, Levin VA. Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol. 2007;67:323–6. https://doi.org/10.1016/j.ijrobp.2006.10.010.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatric Hematology-Oncology, Hospital Infantil Universitario del Niño Jesús, Avenida Menendez Pelayo 65, 28009, Madrid, Spain

    G. Cañedo, L. Madero & A. Lassaletta

  2. Department of Radiology, Hospital Infantil Universitario del Niño Jesús, Madrid, Spain

    I. Solis

  3. Department of Radiation Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain

    C. González-San Segundo

Authors
  1. G. Cañedo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Solis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. González-San Segundo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. Madero
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Lassaletta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Lassaletta.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants performed by any of the authors.

Informed consent

For this type of study formal consent is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cañedo, G., Solis, I., González-San Segundo, C. et al. Treatment of radiation-induced myelopathy with bevacizumab. Clin Transl Oncol 22, 957–960 (2020). https://doi.org/10.1007/s12094-019-02209-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-019-02209-5

Keywords

Search

Navigation